Though much has been documented on the biological activity of honey, no scientific report was seen on the antibacterial activity of honey from Oku, Mbengwi and Ngaoundéré in Cameroon. Our aim was to study the in vitro antibacterial activity of honey produced from these places against clinical isolates. Honey samples were tested for antibacterial activity at concentrations from 100 to 20% volume per volume (v/v) against clinical bacterial isolates using agar well diffusion method. MICs and MBCs of honey samples (49.02 to 1.53% v/v) were determined using broth and agar media respectively. Ciprofloxacin was used as reference substance (120 to 0.5 µg/ml). Honey pH was measured using CYBOW11 test strips. Data were analysed with the help of statistical package for social sciences (SPSS), version 19. These honey samples inhibited the studied bacterial growth at concentrations ≥ 40% with S. aureus and E. coli being more susceptible. Antibacterial activities at concentrations > 60% were comparable to that of the reference drug at p=0.05. The MICs and MBCs ranged from 12.25 to 49.02%. The pH of honeys was estimated to be 5. Oku, Mbengwi and Ngaoundéré honey samples showed antibacterial activity against some bacteria known to cause infectious diseases in humans.
INTRODUCTION
The use of honey in medicine dates far back in history. Many infections have been reported treated using honey (Anna et al., 2015) . It has been used for dressing wounds (burns, surgical wounds, and skin ulcers) probably due to its antimicrobial activity (Amal, 2014; Manisha and Shyamapada, 2011) and also the fact that honey speeds up the growth of new tissues. It reduces pain and odour quickly (Lusby et al., 2002) . Moreover, honey has served as offerings to gods and an embalming fluid (Amal, 2014) .
Antibacterial and antifungal properties of honey against some microbial species have been reported (Chute et al., 2010; Kwakman et al., 2010) . More recently, honey has been reported to have an inhibitory effect to many species of bacteria including aerobes and anaerobes, Gram positives, and Gram negatives (Maria et al., 2011) .
The mechanisms involved in antibacterial activity of honey is linked to high osmotic nature and naturally low pH (3.2-4.5) (Kwakman and Zaat, 2012) , ability to produce hydrogen peroxide (Subrahmanyam et al., 2001; Mahendran and Kumarasamy, 2015) and the presence of phytochemical factors such as tetracycline derivatives, peroxides, amylase, fatty acids, phenols, ascorbic acid, terpenes, benzyl alcohol and benzoic acid (Shears, 2000; Wasihun and Kasa, 2016) . The use of honey as an alternative antimicrobial therapy could be attributed to the fact that it is easily availability, cheap, non-toxic and moreover bacterial resistance to it is yet to be reported (Zainol et al., 2013) .
Several types of bacteria, commonly involved in wound infections like Escherichia coli, Staphylococcus aureus, Proteus mirabilis, Klebsiella spp., Streptococcus faecalis and Pseudomonas aeruginosa are susceptible to honey regardless of their resistance to antibiotics (Lusby et al., 2005; George and Cutting, 2007; Cooper, 2008) .
Although much is documented on the biological activity of honey, no scientific report was seen on the antibacterial activity of honey from three areas in Cameroon. (Cheesbrough, 2006) .
Preparation of microbial suspension for sensitivity testing
The bacteria considered in this study were clinical isolates obtained from the microbiology section of the laboratory, which are known to cause skin, gastrointestinal and respiratory infections. These organisms were: Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae. These isolates were stored in the refrigerator (2-8 o C) and sub-cultured prior to each testing in their respective media at 37 o C for 24 hours. Stock bacterial inoculum suspensions were prepared in sterile normal saline. Three-four well isolated colonies were picked using the inoculating loop and suspended in saline under aseptic conditions. Each suspension was adjusted visually to 0.5 McFarland turbidity standards (Cheesbrough, 2006) .
Agar well diffusion assay
In vitro antibacterial activity of honey preparations was evaluated using the agar well-diffusion assay (Ramalivhana et al., 2014; Teke et al., 2011) . Prepared Mueller Hinton Agar culture media were brought to room temperature after removal from the refrigerator. The plates were labelled with the names of organisms, date of inoculation, place of origin of honey samples, and the different honey concentrations in %v/v. The prepared inoculums were used to flood the cultured plates. Plates were allowed to dry for 30 minutes at 37 o C and later punched with a sterile cork borer to make six equidistant wells of 5 mm diameter each, into which 50 µl of the different honey concentrations were transferred using a 100 µl pipette. These were then allowed to stand for 15 minutes for prediffusion to take place and later incubated at 37 o C for 24 hours. All plates were later observed for inhibition zone diameters and measured using a ruler. The positive (standard antibiotics ciprofloxacin, 2 mg/ml) control was performed by placing 10 µg per well (50 µl of 0.2 µg/µl solution) at the centres of each plate. Negative control was performed by transferring 50 µl sterile distilled water into one of the wells. Each assay was carried out in triplicate and the mean calculated.
Determination of minimum inhibitory concentration (MIC)
The honey samples (1 ml) were serially diluted separately in 5 ml test tubes previously containing 1ml Mueller Hinton broth medium to final concentrations of 50, 25, 12.5, 6.25, 3.125 and 1.5625% v/v. Each microorganism was adjusted to 1.5×10 8 CFU/ ml and 20 µl dispensed into the test tubes. The actual test concentrations of honey now became 49.02, 24.51, 12.25, 6.13, 3.06 and 1.53% v/v. Two control tubes were made: a negative control containing honey and broth medium but no microorganisms; a positive control containing broth medium and microorganism but without honey. Ciprofloxacin was used as reference substance in a range from 120 to 0.5 µg/ml. All the test tubes were incubated at 37 °C for 24 h and the turbidity of each was visually inspected and compared with the controls. The lowest of the honey test concentrations in clear test tubes (Donkeng et al., 2014) was considered as the MIC.
Determination of minimum bactericidal concentration (MBC)
All the test tubes (for different honey concentrations) indicating no visible sign of growth or turbidity in as observed in MIC determination assay, were further sub-cultured on sterile Mueller Hinton agar plates by streak plate method. The plates were then incubated at 37 °C for 24 h. The least concentration that did not show growth of test organisms was considered as the MBC for each honey sample against a bacterial type.
Determination of pH for the different honey types
The pH measurement was carried out on all the different honey concentrations using CYBOW11 test strips. These strips were dipped into the various honey concentrations, blotted on a tissue paper and the colour change matched with the chart attached to the container to get the pH.
Data management and analysis
Data on inhibition zone diameters were analysed using statistical package for social sciences (SPSS), version 19. StudentNewman-Keuls test was used to compare inhibition diameters at different test concentrations. MICs and MBCs are expressed as % of honey.
Ethical considerations
Administrative authorization was obtained from the Regional Hospital Bamenda to carry out the study.
RESULTS

Agar well diffusion assay
The honey samples from Oku, Mbengwi and Ngaoundéré inhibited the growth of all the bacteria under study at concentrations greater than or equal to 40%. The inhibitory zone diameters (Figure 1 ) produced by the different honey samples are given in Tables 1-3 . Honey at 100% gave the highest inhibitory zone diameters which were observed to decrease with dilution of honey. The bacteria S. aureus and E. coli were more susceptible to all the honey samples. This was followed by P. aeruginosa and K. pneumoniae with decreasing susceptibility. In most cases the activities of these honey samples at concentrations greater than 60% were comparable to that of the reference drug at p=0.05.
MIC and MBC of honey samples
The MICs and MBCs of the studied honey samples against bacterial growth (Table  4) showed that values range from 12.25 to 49.02% of honey. The MICs for the Oku, Mbengwi and Ngaoundéré honey samples were the same (12.25%) for S. aureus and E. coli, being more sensitive compared to P. aeruginosa and K. pneumoniae.
pH of samples
The pH was estimated to be 5 for all the honey concentrations. The results obtained showed that the tested honeys exhibited a level of antibacterial activity which generally increased with increase in honey concentration. The different honeys possessed potential antibacterial activity against Gram negative bacterium (E. coli). This is in accordance with the previous report by Mohapatra et al. (2011) , indicating that raw and processed honeys have potential activity against this bacterium. Oku honey had moderate growth inhibitory effects on P. aeruginosa, K. pneumoniae and S. aureus. Some honey types (Yemeni Sidr and Egyptian honeys) are observed to have moderate activity on these microorganisms compared to others (Amal, 2014) . The degree of antibacterial activity varied according to the type of bacterium and type of honey. The observed differences in the activity of the different honeys at various concentrations, may suggest that site difference, as well as the nature of honey production influence their inhibitory activities (Manisha and Shyamapada, 2011) . Some reasons for variations seen between bacteria response to honeys might be due to difference in their cellular organization of the bacteria.
The pH was estimated for all the different honeys and their concentrations using CYBOW 11test strips to be 5, which is acidic. This is in agreement to the work done by Ball (2007) , showing that honey is acidic. Moreover, high osmotic effect (about 80% wt/vol of concentrated sugars) (Ramalivhana et al., 2014) and microorganism sensitivity to hydrogen peroxide (produced by glucose oxidase originating from the bees) found in honey (Ramalivhana et al., 2014; Paulus et al., 2008) constitute inhibitory factors to bacterial growth (Amal, 2014; Manisha and Shyamapada, 2011) .
The MICs and MBCs values for all the tested honeys showed potential bactericidal and bacteriostatic activities against the studied bacteria. Our results corroborate with those of other researchers (Allen et al., 2000; Getaneh et al., 2013; Ahmed et al., 2014) . S. aureus was more sensitive to the honey samples. This bacterium is known to infect wounds and being susceptible to our honey types implies that theses honey could be applied externally for wound treatment. It is documented that honey is used in the treatment of infected wound (Kingsley, 2001) .
It was observed that the % (v/v) of Oku, Mbengwi and Ngaoundéré honey samples that completely inhibited growth for S. aureus, E. coli, K. pneumoniae and P. aeruginosa varied from 6.13 -24.51%. Our values are similar to the results of Wasihun and Kasa (2016) but at the same time higher than those (1.8 to 10.8%, and 10 to 11.5 %) cited in the work of Wasihun and Kasa (2016) and the report of Getaneh et al. (2013) respectively on the antibacterial activity of Tazma honey on MRSA. These differences in the antibacterial activity of honeys could be due to the different sources and/or species of bees (Wasihun and Kasa, 2016) responsible for honey making. Elsewhere, alkaloids, tannins, flavonoids were found in honey samples (Adeniyi et al., 2016) . These compounds are known to possess antibacterial activities (Adeniyi et al., 2013; Houria et al., 2014; Zintchem et al., 2015) and could be responsible for the differential antimicrobial activities observed in this study. Other variables such as weather and climatic changes (Wasihun and Kasa, 2016) influence honey growth inhibitory action on microorganisms.
Conclusion
The honey samples from Oku, Mbengwi and Ngaoundéré showed considerable antibacterial activity against S. aureus, E. coli, P. aeruginosa and K. pneumoniae which are known to cause infectious diseases in humans. However, further studies on the standardization and clinical evaluation on the effect of this natural substance are needed for its wide use in the prevention and treatment of bacterial infections.
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